特拉马多尔诱导的氧化性丸损伤和生殖功能障碍和腺三酸盐之间的关系
Fevzi Bedir1, Hüseyin Kocatürk1, Mehmet Sefa Altay1
1Department of Urology, Health Sciences University, Erzurum Regional Training and Research Hospital, Erzurum 25070, Turkey.
Life (Basel, Switzerland)
|July 29, 2025
概括
腺三酸盐 (ATP) 可能会保护男性免受特拉马多尔诱导的不孕症. 在暴露于特拉马多尔的老鼠中,ATP治疗减轻了氧化应激和炎症,保持了丸功能和形态.
科学领域:
- 生殖毒理学 生殖毒理学
- 生物化学 生物化学
- 药理学 药理学 是一个学科.
背景情况:
- 特拉马多尔是一种广泛使用的止痛药,可以诱导男性生殖障碍.
- 潜在的机制包括氧化应激,炎症和能量耗尽 (ATP损失).
研究的目的:
- 为了研究腺三酸盐 (ATP) 对特拉马多尔诱导的丸损伤和不孕症的保护作用,在老鼠模型中.
主要方法:
- 鼠被分为四组:对照组,仅使用特拉马多尔,仅使用ATP和使用ATP+特拉马多尔.
- 治疗包括每天三周内内ATP (4毫克/公斤) 和口服特拉马多尔 (50毫克/公斤).
- 对丸组织进行了生物化学和组织病理学分析;评估了生殖功能.
主要成果:
- 特拉马多尔暴露导致氧化应激增加,炎症,抗氧化剂减少,男性生殖能力受损.
- 组织病理学发现,在接受过特拉马多尔治疗的老鼠中,精子管道变薄,生殖细胞异常和莱迪格细胞增多.
- ATP治疗显著抵消了特拉马多尔的不良影响,减少了氧化剂和炎症,同时保持了丸形态和功能.
结论:
- 特拉马多尔诱导显著的丸损伤和不孕症,由氧化应激和炎症介导.
- 腺三酸盐 (ATP) 证明具有保护作用,可以减轻特拉马多尔诱导的生殖毒性.
- ATP显示了治疗特拉马多尔诱导的男性不孕症的治疗潜力.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Cellular Injury I: Introduction
Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...


